REC-1245

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic CancerNCT06678659RXRXPhase 1, Phase 2Recruiting2029-07Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.